Cargando…
Recurrent Chylous Pleural Effusions in a Patient Treated With Dasatinib
Dasatinib is a second-generation BCR-ABL tyrosine kinase inhibitor (TKI) that is approved for the treatment of chronic myeloid leukemia (CML), a myeloproliferative disorder seen commonly in adults over the age of 50. Dasatinib is superior in tolerance and efficacy to first-generation TKIs such as im...
Autores principales: | Nasir, Syed Alishan, Calavia Liano, Hugo, Manfredi, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450929/ https://www.ncbi.nlm.nih.gov/pubmed/36106302 http://dx.doi.org/10.7759/cureus.27778 |
Ejemplares similares
-
Chylous Ascites and Pleural Effusion Treated With Intravenous Octreotide
por: Ghimire, Subash, et al.
Publicado: (2020) -
A Rare Case of a Chylous Pleural Effusion as the Initial Manifestation of Synchronous Tumors
por: Sequeira, Mafalda, et al.
Publicado: (2023) -
Recurrence of Angioimmunoblastic T-cell Lymphoma in a Patient Successfully Treated for Hodgkin’s Lymphoma: A Case Report
por: Nasir, Syed Alishan, et al.
Publicado: (2022) -
An Atypical Presentation of Twiddler’s Syndrome: A Case Report
por: Liano Calavia, Hugo, et al.
Publicado: (2022) -
A Rare Case of Sjogren’s Syndrome-Related Recurrent Pleural Effusion
por: Alnabwani, Dina, et al.
Publicado: (2021)